Novo Nordisk

Media’s FOIA Requests Target FDA Gaps

FOIAengine: Growing Scrutiny of Drug Safety and Enforcement  As GLP-1 weight-loss drugs surge in popularity,...

Hedge Funds Target Novo’s $16.5 Billion Trouble Magnet

FOIAengine: Catalent Targeted by 259 FOIA Requests Since 2020 Wall Street got unusually curious last...

More Questions About Obesity Drug Makers

FOIAengine:  How Lilly, Novo Nordisk, Others Use FOIA Welcome to 2025.  At PoliScio Analytics, we...

Novo Holdings Hones in on Catalent

As pharmaceutical companies race to find the next generation of medicines, Novo Holdings announced...

Morgan & Morgan Targets Weight Control Drugs

FOIAengine Reveals Threat of Litigation Personal injury law firm Morgan & Morgan is gearing up...

Will the Feds Classify Marijuana as a “Safe”...

In FOIAengine, Media Requests Seek the Answer When word leaked in late August that the Department...

Riding the Ozempic Wave

FOIAengine Reveals a Giant Hedge Fund‘s Interest Elon Musk sounded ecstatic when he tweeted out the...

Novo Nordisk Will Acquire Dicerna Pharmaceuticals For $3.3B

Pharmaceutical company Novo Nordisk, best known for its insulin and diabetes-related  products, will acquire...